Entity Common Stock, Shares Outstanding of Y-mAbs Therapeutics, Inc. from 12 Nov 2018 to 04 Aug 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Y-mAbs Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Nov 2018 to 04 Aug 2025.
  • Y-mAbs Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 04 Aug 2025 was 45,438,420, a 1.9% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 45,438,420 +868,586 +1.9% 04 Aug 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 45,276,915 +1,394,277 +3.2% 25 Apr 2025 10-K/A 29 Apr 2025 2024 FY
Q3 2024 44,789,076 +1,167,458 +2.7% 01 Nov 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 44,569,834 +949,642 +2.2% 05 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 43,882,638 +204,871 +0.47% 30 Apr 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 43,621,618 -46,512 -0.11% 06 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 43,620,192 -99,357 -0.23% 03 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 43,677,767 -40,398 -0.09% 23 Mar 2023 10-K 30 Mar 2023 2022 FY
Q3 2022 43,668,130 +24,214 +0.06% 02 Nov 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 43,719,549 +143,549 +0.33% 03 Aug 2022 10-Q 08 Aug 2022 2021 Q3
Q1 2022 43,718,165 +146,746 +0.34% 04 May 2022 10-Q 09 May 2022 2022 Q1
Q3 2021 43,643,916 +3,130,259 +7.7% 02 Nov 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 43,576,000 +3,561,481 +8.9% 03 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 43,571,419 +3,814,725 +9.6% 04 May 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 40,513,657 +785,241 +2% 03 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 40,014,519 +5,820,853 +17% 04 Aug 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 39,756,694 +5,563,028 +16% 10 Mar 2020 10-K 12 Mar 2020 2019 FY
Q3 2019 39,728,416 +5,534,750 +16% 01 Nov 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 34,193,666 09 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 34,193,666 14 Mar 2019 10-K 22 Mar 2019 2018 FY
Q3 2018 34,193,666 12 Nov 2018 10-Q 13 Nov 2018 2018 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.